EP1115295A2 - Method of protecting heat- or oxygen-labile compounds to preserve activity and bioavailability - Google Patents
Method of protecting heat- or oxygen-labile compounds to preserve activity and bioavailabilityInfo
- Publication number
- EP1115295A2 EP1115295A2 EP99948490A EP99948490A EP1115295A2 EP 1115295 A2 EP1115295 A2 EP 1115295A2 EP 99948490 A EP99948490 A EP 99948490A EP 99948490 A EP99948490 A EP 99948490A EP 1115295 A2 EP1115295 A2 EP 1115295A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- compound
- oxygen
- solution
- labile
- heat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 87
- 238000000034 method Methods 0.000 title claims abstract description 44
- 230000000694 effects Effects 0.000 title abstract description 10
- 108010010803 Gelatin Proteins 0.000 claims abstract description 32
- 239000008273 gelatin Substances 0.000 claims abstract description 32
- 229920000159 gelatin Polymers 0.000 claims abstract description 32
- 235000019322 gelatine Nutrition 0.000 claims abstract description 32
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 32
- 239000007800 oxidant agent Substances 0.000 claims abstract description 18
- 239000003999 initiator Substances 0.000 claims abstract description 17
- 230000015556 catabolic process Effects 0.000 claims abstract description 13
- 238000006731 degradation reaction Methods 0.000 claims abstract description 13
- 235000010410 calcium alginate Nutrition 0.000 claims abstract description 12
- 239000000648 calcium alginate Substances 0.000 claims abstract description 12
- 229960002681 calcium alginate Drugs 0.000 claims abstract description 12
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims abstract description 12
- 229920000642 polymer Polymers 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 10
- 238000012545 processing Methods 0.000 claims abstract description 7
- 239000000243 solution Substances 0.000 claims description 26
- 235000010443 alginic acid Nutrition 0.000 claims description 13
- 229920000615 alginic acid Polymers 0.000 claims description 13
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 12
- 229910052708 sodium Inorganic materials 0.000 claims description 12
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 11
- 229940072056 alginate Drugs 0.000 claims description 11
- 239000011734 sodium Substances 0.000 claims description 11
- 235000010418 carrageenan Nutrition 0.000 claims description 8
- 239000000679 carrageenan Substances 0.000 claims description 8
- 229920001525 carrageenan Polymers 0.000 claims description 8
- 229940113118 carrageenan Drugs 0.000 claims description 8
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 8
- 230000037406 food intake Effects 0.000 claims description 7
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 6
- 229910001424 calcium ion Inorganic materials 0.000 claims description 6
- 238000003860 storage Methods 0.000 claims description 6
- 239000013589 supplement Substances 0.000 claims description 6
- 229920002907 Guar gum Polymers 0.000 claims description 5
- 235000010417 guar gum Nutrition 0.000 claims description 5
- 239000000665 guar gum Substances 0.000 claims description 5
- 229960002154 guar gum Drugs 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 102000009027 Albumins Human genes 0.000 claims description 4
- 108010088751 Albumins Proteins 0.000 claims description 4
- 229910052783 alkali metal Inorganic materials 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 235000021466 carotenoid Nutrition 0.000 claims description 4
- 150000001747 carotenoids Chemical class 0.000 claims description 4
- 239000005018 casein Substances 0.000 claims description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 4
- 235000021240 caseins Nutrition 0.000 claims description 4
- 239000011159 matrix material Substances 0.000 claims description 4
- 229920001282 polysaccharide Polymers 0.000 claims description 4
- 239000005017 polysaccharide Substances 0.000 claims description 4
- 239000011253 protective coating Substances 0.000 claims description 4
- 235000018102 proteins Nutrition 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 239000000758 substrate Substances 0.000 claims description 4
- 235000010493 xanthan gum Nutrition 0.000 claims description 4
- 239000000230 xanthan gum Substances 0.000 claims description 4
- 229920001285 xanthan gum Polymers 0.000 claims description 4
- 229940082509 xanthan gum Drugs 0.000 claims description 4
- -1 alkali metal salt Chemical class 0.000 claims description 3
- 150000001340 alkali metals Chemical class 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 2
- 229910021645 metal ion Inorganic materials 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 108010076119 Caseins Proteins 0.000 claims 3
- 150000004676 glycans Chemical class 0.000 claims 3
- 239000003381 stabilizer Substances 0.000 claims 3
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 150000001447 alkali salts Chemical class 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 33
- 238000001125 extrusion Methods 0.000 abstract description 19
- 230000007423 decrease Effects 0.000 abstract description 2
- 230000003647 oxidation Effects 0.000 abstract description 2
- 238000007254 oxidation reaction Methods 0.000 abstract description 2
- 150000003254 radicals Chemical class 0.000 abstract 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 25
- 235000012680 lutein Nutrition 0.000 description 22
- 239000001656 lutein Substances 0.000 description 22
- 229960005375 lutein Drugs 0.000 description 22
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 22
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 22
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 22
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 19
- 229910052760 oxygen Inorganic materials 0.000 description 19
- 239000001301 oxygen Substances 0.000 description 19
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 12
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 11
- 235000013734 beta-carotene Nutrition 0.000 description 11
- 239000011648 beta-carotene Substances 0.000 description 11
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 11
- 229960002747 betacarotene Drugs 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 238000005538 encapsulation Methods 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- 235000010413 sodium alginate Nutrition 0.000 description 7
- 239000000661 sodium alginate Substances 0.000 description 7
- 229940005550 sodium alginate Drugs 0.000 description 7
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 230000001681 protective effect Effects 0.000 description 5
- 241000282472 Canis lupus familiaris Species 0.000 description 4
- 230000035699 permeability Effects 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 229920000161 Locust bean gum Polymers 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 235000010420 locust bean gum Nutrition 0.000 description 3
- 239000000711 locust bean gum Substances 0.000 description 3
- 239000004005 microsphere Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical class N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000199919 Phaeophyceae Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000011149 active material Substances 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940099112 cornstarch Drugs 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 125000005613 guluronic acid group Chemical group 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 239000011257 shell material Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229910021529 ammonia Chemical class 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- AEMOLEFTQBMNLQ-YBSDWZGDSA-N d-mannuronic acid Chemical compound O[C@@H]1O[C@@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-YBSDWZGDSA-N 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000012438 extruded product Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007962 solid dispersion Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229920003176 water-insoluble polymer Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/256—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/275—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
- A23L29/281—Proteins, e.g. gelatin or collagen
- A23L29/284—Gelatin; Collagen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
Definitions
- the invention relates to a method of protecting heat-labile and/or oxygen-labile compounds and, more specifically, to heat- and/or oxygen-labile compounds that are coated to protect the activity of the compounds or the labile component of a food or feedstuff, particularly following extrusion, without sacrificing the bioavailability of the compounds upon ingestion 2 Background of the Art
- Encapsulation of the active compounds protects them against oxygen degradation not only through physical protection from contact with oxygen, but also by protecting them against interaction with oxidizing agents and free-radical initiators that may be present in the substrate, such as a food product, to which the encapsulated compounds have been added
- oxidizing agents and free-radical initiators that may be present in the substrate, such as a food product, to which the encapsulated compounds have been added
- polyvalent metal ions such as iron, copper, manganese, and chromium
- the presence of these oxidizing agents ordinarily accelerates the oxygen degradation of the unprotected active compounds, particularly if elevated temperatures or pressures are present
- encapsulation of the active compounds will protect them from radical initiators
- encapsulation of the active compounds serves another purpose Certain of these active compounds, such as lutein, are not oxidizing agents or free-radical initiators themselves, but upon degradation become oxidizing agents or free-radical initiators.
- the process of coating of the known oxidizing agents or free-radical initiators that may be added to the product containing the labile compounds.
- the process of the present invention may be used either directly to protect the labile compounds themselves or indirectly by limiting the activity of oxidizing agents and free-radical initiators.
- the compounds, either the labile compounds or the oxidizing agents or free-radical initiators, or both, being added to the product are subject to coating to provide the protective effect.
- the invention consists of a method of encapsulating heat- and/or oxygen-labile compounds with a protective coating that will limit the loss in activity of the compound during processing, particularly extrusion, and storage of a food product containing the encapsulated compound while maintaining a high degree of bioavailability of the compound throughout the shelf life of the food product and when the food product is ingested.
- oxidizing agents or free-radical initiators including compounds which release or become such oxidizing agents or free-radical initiators upon degradation, are encapsulated with a protective coating.
- the invention allows for the supplementation of food products with heat- and/or oxygen labile compounds in combination with other desirable supplements, such as minerals, which are normally antagonistic.
- An aqueous solution of sodium alginate is prepared and the compound to be protected is added.
- One or more ancillary polymeric compound such as carrageenan, locust bean gum, and gelatin are used to improve the encapsulation.
- the solution is sprayed onto a bath of calcium chloride solution, forming calcium alginate beadlets in which are dispersed a volume of the solution including the protected compound.
- the beadlets are separated and dried.
- the beadlets exhibit enhanced stability of the protected compounds through the extrusion process.
- Fig. 1 is a graphical representation of the loss in lutein and ⁇ -carotene at various
- Fig. 2 is a graphical representation of oxygen absorption of beadlets protected by gelatin and the process of the present invention.
- Fig. 3 is a graphical representation of the levels of lutein remaining in beadlets of the lutein and protected by highly cross-linked gelatin, 50% cross-linked gelatin, and the process of the present invention before and after exposure to 50 psi oxygen in an oxygen bomb at standard temperature for 100 hours.
- the piesent method of forming encapsulated biologically active compounds compnses the steps of dissolving sodium algmate in water at room temperatui e to produce a solution of sodium algmate Added to the solution is an ancillary polymeric compound, such as gelatin Other ancillary polymeric agents, such as carrageenan, locust bean gum, guar gum, or the like may be added to the solution or substituted in whole or m part for the gelatin
- the biologically active compound(s) are also added to the solution
- the mixture is sprayed onto an aqueous bath having a source of calcium ions, such as dissolved calcium chloride
- the beadlets that aie formed are filteied out of the solution and dried
- the ranges of the sodium alginate, ancillary polymeric mate ⁇ al(s), and biologically active compound(s) to be added m the solution are provided on a total dry mattei weight basis
- Amounts of algmate less than the recited range do not lesult in satisfactory beadlet formation
- Amounts of algmate in excess of the recited range do not have satisfactory oxygen impermeability
- Amounts of gelatin less than the recited range result in a beadlet with unsatisfactory oxygen permeability and amounts m excess of the recited range mterfei e with formation of the algmate web or substrate
- Amounts of the biologically active compound(s) below the recited range will not adversely affect the effectiveness of protecting and dehveimg a biologically available compound, but are not likely to be commercially feasible in that an excess amount of protective mate ⁇ al is utilized
- Amounts of the biologically active compound(s) greater than the recited range may mterfei e with formation of an effectively protective beadlet and will adveisely affect the economy of the piocess by increasing the amount of the active compound(s) that is lost dining processing and storage
- the ratio of water to dry ingredients used in the solution necessarily depends on the particular one or combination of ancillary polymeric compounds that are used
- carrageenan is consideiably more viscous at lower concentrations than gelatin
- the ratio falls within a range of between about 15 1 and about 7 1 , watei dry ingiedients, with a preferred range of between about 12 1 and about 8 1 If less than the lecited range of water is used, the viscosity of the solution will start to prevent effective pumping and/oi spraying of the solution If greater than the recited range of water is used, it is difficult to form discrete beadlets
- lutein a carotenoid that is believed to have immune system stimulating effects in dogs, to protect the lutein against degradation du ⁇ ng the extrusion piocess and throughout the shelf life of a food product without adversely affecting its bioavailability upon ingestion of the food product
- Alginate commercially available as alginic acid, sodium salt, commonly called sodium algmate, is a linear polysaccha ⁇ de normally isolated from marine brown seaweed and algae
- the copolymer consists of two uromc acids D-mannuronic acid and L-guluromc acid Alginic acid can be either water soluble oi insoluble depending on the type of the associated salt
- the salts of sodium, other alkali metals, and ammonia are soluble, whereas the salts of polyvalent cations, e g , calcium, are water insoluble
- Polyvalent cations bind to the polymer whenevei there aie two neighbo ⁇ ng guluronic acid residues Accordingly, the polyvalent cations are responsible for the cross-linkmg of both different polymer molecules and different parts of the same polymer chain
- the exchange of calcium ions for sodium ions is carried out under relatively mild conditions In that the method of gelation is based on the availability of guluronic acid residues,
- samples of lutein encapsulated m highly cross-linked gelatin and m model ately cross-lmked gelatin were also prepared according to the following methods A 1000 g sample of FloiaGLO ® 20% Liquid (Kemm Foods) was prepared using the disk method Shell material solutions were made using 25% Gelatin Bloom 300 and 5%
- microspheres were collected on cornstarch, allowed to dry and then sieved After the microspheres were collected, they were cross-linked using glutaraldehyde at 5% of the total weight of gelatin Glutaraldehyde, ethanol and water were combined in the ration of 1 8 1 to prepare the cross-linkmg solution
- the microspheres weie added to the solution and allowed to cross-lmk for an hour They were placed in a water bath and heated for 10 minutes, then harvested and dried
- the resulting extruded product has an initial moisture content of about 25% and is dried between about 15 and 30 minutes at a temperature
- Beta-Carotene 10% from Roche (identified as having beta-carotene finely dispersed in a starch-coated matrix of gelatin and carbohydrates), Beta-Carotene 1 % B from Roche (identified as having beta-carotene finely dispersed in a starch-coated matrix of fish gelatin, fructose, glycerol), and Lucarotin® from BASF (identified as special food-grade beta-carotene containing a minimum of 7% beta-carotene)
- Fig 1 shows the stability of the lutein in the control and by encapsulation using the three techniques
- Oxygen permeability of the three encapsulated lutein products was tested by in an oxygen bomb under 50 psi oxygen for 100 hours with the oxygen bomb kept at room temperature during analysis The results of the tests are set out in Fig 2 and are summarized in Table 1 and Fig 3
- Calcium alginate is a non-thermally reversible and water insoluble polymer
- the gelatin added to the alginate in the present invention does not chemically react with the alginate, either sodium or calcium alginate There is, however, believed to be a degree of physical binding that occurs as the gelatin thermally folds and the alginate cross-links The physical binding that occurs as the gelatin thermally folds and the alginate cross-links.
- the beadlets that are produced are a solid dispersion of the lutein in the encapsulating material.
- the small amount of loss of lutein observed in beadlets of the present invention is believed to be due to surface crystals of lutein that are only thinly covered by the encapsulating material.
- a stabilizing compound, such as an antioxidant may be added to the heat- and/or oxygen- labile compound prior to its addition to the solution of protecting materials to protect further the labile compound.
- the active compound is not chemically altered by the encapsulation process.
- the crystalline lutein used in the specific embodiments is not changed by the process. Throughout the encapsulation process and extrusion of a food product to which the beadlets of encapsulated lutein have been added, the lutein is still present as the discrete lutein crystals that are present in the starting material.
- the amount of sodium alginate can be adjusted through a range to achieve the results desired in specific applications.
- concentration of ancillary polymeric compounds may not be critical for a given application. While gelatin is the preferred ancillary polymeric
- polymeric materials that could be used either alone or in combination with gelatin or each other include albumin, casein or other proteins, carrageenan, guar gum, xanthan gum, or other polysaccharides.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Dispersion Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Fodder In General (AREA)
- General Preparation And Processing Of Foods (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Jellies, Jams, And Syrups (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Abstract
Description
Claims
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US307414 | 1989-02-07 | ||
US10180398P | 1998-09-25 | 1998-09-25 | |
US101803P | 1998-09-25 | ||
US09/307,414 US6146671A (en) | 1999-05-08 | 1999-05-08 | Method and protecting heat-or oxygen-labile compounds to preserve activity and bioavailability |
PCT/US1999/022427 WO2000018254A2 (en) | 1998-09-25 | 1999-09-24 | Method of protecting heat- or oxygen-labile compounds to preserve activity and bioavailability |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1115295A2 true EP1115295A2 (en) | 2001-07-18 |
EP1115295A4 EP1115295A4 (en) | 2004-12-15 |
Family
ID=26798648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99948490A Withdrawn EP1115295A4 (en) | 1998-09-25 | 1999-09-24 | Method of protecting heat- or oxygen-labile compounds to preserve activity and bioavailability |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1115295A4 (en) |
JP (1) | JP3605360B2 (en) |
AU (1) | AU758534B2 (en) |
BR (1) | BR9914070A (en) |
WO (1) | WO2000018254A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2889910B1 (en) * | 2005-08-25 | 2012-02-10 | Virbac Sa | PRODUCT FOR THE PREPARATION OF SUPPLEMENTAL FEEDS FOR ANIMALS |
CA2674529A1 (en) * | 2007-01-19 | 2008-07-24 | The Iams Company | Composition and method of stabilized sensitive ingredient |
WO2013093630A2 (en) | 2011-12-22 | 2013-06-27 | Pronova Biopharma Norge As | Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof |
EP2988614B1 (en) * | 2013-03-28 | 2017-08-16 | DSM IP Assets B.V. | Lutein composition suitable for infant food formulations |
WO2016176466A1 (en) | 2015-04-28 | 2016-11-03 | Mars, Incorporated | Process of preparing a sterilized wet pet food product |
CN109265711B (en) * | 2018-09-03 | 2021-12-03 | 胡权 | Preparation method of polymer particles |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987001587A1 (en) * | 1985-09-17 | 1987-03-26 | Biocompatibles Limited | Microcapsules |
US4695463A (en) * | 1985-05-24 | 1987-09-22 | Warner-Lambert Company | Delivery system for active ingredients and preparation thereof |
US4702921A (en) * | 1984-07-11 | 1987-10-27 | Q.P. Corporation | Method for preparing fish-egg-like edible products |
US5211980A (en) * | 1980-10-03 | 1993-05-18 | Cox James P | Lipid pelletization methods, apparatus and products |
US5639467A (en) * | 1992-05-29 | 1997-06-17 | The Regents Of The University Of California | Electrostatic process for manufacturing coated transplants and product |
DE19644343A1 (en) * | 1996-10-25 | 1998-04-30 | Privates Inst Bioserv Gmbh | Taste-neutral microcapsules, process for their preparation and their use |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4389419A (en) * | 1980-11-10 | 1983-06-21 | Damon Corporation | Vitamin encapsulation |
US5427935A (en) * | 1987-07-24 | 1995-06-27 | The Regents Of The University Of Michigan | Hybrid membrane bead and process for encapsulating materials in semi-permeable hybrid membranes |
DE4141351A1 (en) * | 1991-12-14 | 1993-06-17 | Basf Ag | STABLE POWDERFUL VITAMIN AND / OR CAROTINOIDE PREPARATES AND PROCESS FOR THEIR PREPARATION |
EP0689834A3 (en) * | 1994-07-01 | 1996-06-05 | Willem Jacob Serfontein | Sustained release food or feed supplement containing vitamins and minerals |
JPH1147581A (en) * | 1997-07-30 | 1999-02-23 | Takasago Internatl Corp | Slow release capsule and its preparation |
-
1999
- 1999-09-24 BR BR9914070-5A patent/BR9914070A/en not_active Application Discontinuation
- 1999-09-24 WO PCT/US1999/022427 patent/WO2000018254A2/en active IP Right Grant
- 1999-09-24 JP JP2000571780A patent/JP3605360B2/en not_active Expired - Fee Related
- 1999-09-24 EP EP99948490A patent/EP1115295A4/en not_active Withdrawn
- 1999-09-24 AU AU61655/99A patent/AU758534B2/en not_active Ceased
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5211980A (en) * | 1980-10-03 | 1993-05-18 | Cox James P | Lipid pelletization methods, apparatus and products |
US4702921A (en) * | 1984-07-11 | 1987-10-27 | Q.P. Corporation | Method for preparing fish-egg-like edible products |
US4695463A (en) * | 1985-05-24 | 1987-09-22 | Warner-Lambert Company | Delivery system for active ingredients and preparation thereof |
WO1987001587A1 (en) * | 1985-09-17 | 1987-03-26 | Biocompatibles Limited | Microcapsules |
US5639467A (en) * | 1992-05-29 | 1997-06-17 | The Regents Of The University Of California | Electrostatic process for manufacturing coated transplants and product |
DE19644343A1 (en) * | 1996-10-25 | 1998-04-30 | Privates Inst Bioserv Gmbh | Taste-neutral microcapsules, process for their preparation and their use |
Non-Patent Citations (2)
Title |
---|
PATENT ABSTRACTS OF JAPAN vol. 1999, no. 05, 31 May 1999 (1999-05-31) -& JP 11 047581 A (TAKASAGO INTERNATL CORP), 23 February 1999 (1999-02-23) * |
See also references of WO0018254A3 * |
Also Published As
Publication number | Publication date |
---|---|
WO2000018254A3 (en) | 2000-05-25 |
EP1115295A4 (en) | 2004-12-15 |
AU758534B2 (en) | 2003-03-27 |
JP2002525090A (en) | 2002-08-13 |
WO2000018254A2 (en) | 2000-04-06 |
BR9914070A (en) | 2001-10-16 |
JP3605360B2 (en) | 2004-12-22 |
AU6165599A (en) | 2000-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6146671A (en) | Method and protecting heat-or oxygen-labile compounds to preserve activity and bioavailability | |
KR101175774B1 (en) | Microcapsules having multiple shells and method for the preparation thereof | |
EP1492417B1 (en) | Encapsulated agglomeration of microcapsules and method for the preparation thereof | |
US5690990A (en) | Process for encapsulating the flavor with colloid gel matrix | |
EP0750854B1 (en) | Process for encapsulating a core material with a polymer by high-pressure treatment | |
AU2003219623A1 (en) | Polysaccharide capsules and methods of preparation | |
US8541040B2 (en) | Process for producing protein microparticles | |
EP0494417B1 (en) | Process for crosslinking gelatin and for incorporation a material therein | |
AU758534B2 (en) | Method of protecting heat- or oxygen-labile compounds to preserve activity and bioavailability | |
US3560222A (en) | Method of rapidly developing and stabilizing the cured color in comminuted meat and composition therefor | |
WO2011049447A1 (en) | Barrier composition | |
EP0372669B1 (en) | Stabilized oil and fat powder | |
NO324980B1 (en) | Microcapsules, processes for the preparation of such as well as products which include said microcapsules. | |
WO2014130801A1 (en) | Enteric delivery of functional ingredients for animals | |
US5126328A (en) | Process for crosslinking gelatin | |
US2912332A (en) | Stabilized thiamine composition and method of enriching food products | |
KR102755482B1 (en) | Method of producing for pH-sensitive-release controlled emulsion hydrogel | |
González et al. | Modification strategies of proteins for food packaging applications | |
GB1558590A (en) | Method of producing albumin containing nutrient composition | |
Carrillo-Castillo et al. | Advances in the Development of Hydrogels as an Intelligent Food Packaging for Loading and Release of Natural Compounds | |
CN118058464A (en) | Preparation method of glycosylated pisiform protein nano-composite loaded with curcumin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010423 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 23L 1/30 A |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20041103 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 23K 1/00 B Ipc: 7A 61K 9/16 B Ipc: 7A 23L 1/0562 B Ipc: 7A 23L 1/00 B Ipc: 7A 23L 1/0532 B Ipc: 7A 23L 1/30 A |
|
17Q | First examination report despatched |
Effective date: 20050810 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20100401 |